Scott Leftwich is Director at Calidi Biotherapeutics, Inc. (CLDI). They have made 1 open-market trade across 1 company since 2025, most recently 2025-08-21.
CIK 0001991668
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $250K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLDI | 130,650 | $103K |
Shares reported on the most recent Form 4, priced at the 2025-08-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLDI | BUY | 2025-08-21 | 2025-08-25 | $2.00 | $250K | -7.0% | -9.9% | -22.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.